The US Food and Drug Administration approved one panel-track PMA supplement and no original PMAs during the week of 28 May to 3 June.
The FDA approved a panel-track PMA supplement for TransMedics Inc.’s Organ Care System (OCS) Lung for preservation of donor lungs initially deemed unacceptable for procurement and transplantation based on...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?